U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023

During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2024-09, Vol.42 (Suppl 3), p.125703-125703, Article 125703
Hauptverfasser: Duggar, Christopher, Santoli, Jeanne M., Noblit, Cameron, Moore, Lori B., El Kalach, Roua, Bridges, Carolyn B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 125703
container_issue Suppl 3
container_start_page 125703
container_title Vaccine
container_volume 42
creator Duggar, Christopher
Santoli, Jeanne M.
Noblit, Cameron
Moore, Lori B.
El Kalach, Roua
Bridges, Carolyn B.
description During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures. This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.
doi_str_mv 10.1016/j.vaccine.2024.02.020
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11366301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X24001671</els_id><sourcerecordid>2928247931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-926430a72d3efced8bb26a560afd54ad734881db201c4cae95577d40008096e53</originalsourceid><addsrcrecordid>eNqFUcluFDEQtRCIDIFPAFniwmG68drLCaEJS6SgHCCIm-W2q4NH3fbE7h5pbvwDf8iX4FaGsFyQSqqy6tWren4IPaWkpIRWL7flXhvjPJSMMFESloPcQyva1Lxgkjb30YqwShSCki8n6FFKW0KI5LR9iE54wysi6mqFpqvyY4k3l5_Pzwra4iMnti5N0XXz5ILHudQTXDtIa5wOaYIxFzuIfYij9gbWWHuLB0gp-JSzjh7sGp-BgbGDiPOBBP_49h1_0IflwR-jB70eEjw55lN09fbNp8374uLy3fnm9UVhhBBT0ebzOdE1sxx6A7bpOlZpWRHdWym0rbloGmo7RqgRRkMrZV1bkWU2pK1A8lP06pZ3N3cjWAM-KxnULrpRx4MK2qm_O959VddhryjlVcUJzQwvjgwx3MyQJjW6ZGAYtIcwJ8Va1jBRt3yBPv8Hug1z9Fmfyl0m5QLNKHmLMjGkFKG_u4YStRirtupoglqMVYTlIHnu2Z9S7qZ-OflbK-QP3TuIKhkH2R3rIphJ2eD-s-Inu8-1mw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3132559282</pqid></control><display><type>article</type><title>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Duggar, Christopher ; Santoli, Jeanne M. ; Noblit, Cameron ; Moore, Lori B. ; El Kalach, Roua ; Bridges, Carolyn B.</creator><creatorcontrib>Duggar, Christopher ; Santoli, Jeanne M. ; Noblit, Cameron ; Moore, Lori B. ; El Kalach, Roua ; Bridges, Carolyn B.</creatorcontrib><description>During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures. This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.</description><identifier>ISSN: 0264-410X</identifier><identifier>ISSN: 1873-2518</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2024.02.020</identifier><identifier>PMID: 38360476</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>At risk populations ; Centers for Disease Control and Prevention, U.S ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - prevention &amp; control ; COVID-19 pandemic ; COVID-19 vaccine ; COVID-19 vaccines ; COVID-19 Vaccines - administration &amp; dosage ; Disease control ; Drug stores ; Emergency preparedness ; Humans ; Illnesses ; Immunization ; Immunization Programs - organization &amp; administration ; Information systems ; Infrastructure ; Inventory ; Islands ; Lessons learned ; Medicaid ; Older people ; Pandemics ; Pandemics - prevention &amp; control ; Pediatrics ; Pharmacy ; Public health ; SARS-CoV-2 - immunology ; Severe acute respiratory syndrome coronavirus 2 ; Swine flu ; United States - epidemiology ; Vaccination ; Vaccine distribution ; Vaccines</subject><ispartof>Vaccine, 2024-09, Vol.42 (Suppl 3), p.125703-125703, Article 125703</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><rights>2024. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c444t-926430a72d3efced8bb26a560afd54ad734881db201c4cae95577d40008096e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3132559282?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993,64383,64385,64387,72239</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38360476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duggar, Christopher</creatorcontrib><creatorcontrib>Santoli, Jeanne M.</creatorcontrib><creatorcontrib>Noblit, Cameron</creatorcontrib><creatorcontrib>Moore, Lori B.</creatorcontrib><creatorcontrib>El Kalach, Roua</creatorcontrib><creatorcontrib>Bridges, Carolyn B.</creatorcontrib><title>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures. This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.</description><subject>At risk populations</subject><subject>Centers for Disease Control and Prevention, U.S</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 pandemic</subject><subject>COVID-19 vaccine</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - administration &amp; dosage</subject><subject>Disease control</subject><subject>Drug stores</subject><subject>Emergency preparedness</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Immunization</subject><subject>Immunization Programs - organization &amp; administration</subject><subject>Information systems</subject><subject>Infrastructure</subject><subject>Inventory</subject><subject>Islands</subject><subject>Lessons learned</subject><subject>Medicaid</subject><subject>Older people</subject><subject>Pandemics</subject><subject>Pandemics - prevention &amp; control</subject><subject>Pediatrics</subject><subject>Pharmacy</subject><subject>Public health</subject><subject>SARS-CoV-2 - immunology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Swine flu</subject><subject>United States - epidemiology</subject><subject>Vaccination</subject><subject>Vaccine distribution</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUcluFDEQtRCIDIFPAFniwmG68drLCaEJS6SgHCCIm-W2q4NH3fbE7h5pbvwDf8iX4FaGsFyQSqqy6tWren4IPaWkpIRWL7flXhvjPJSMMFESloPcQyva1Lxgkjb30YqwShSCki8n6FFKW0KI5LR9iE54wysi6mqFpqvyY4k3l5_Pzwra4iMnti5N0XXz5ILHudQTXDtIa5wOaYIxFzuIfYij9gbWWHuLB0gp-JSzjh7sGp-BgbGDiPOBBP_49h1_0IflwR-jB70eEjw55lN09fbNp8374uLy3fnm9UVhhBBT0ebzOdE1sxx6A7bpOlZpWRHdWym0rbloGmo7RqgRRkMrZV1bkWU2pK1A8lP06pZ3N3cjWAM-KxnULrpRx4MK2qm_O959VddhryjlVcUJzQwvjgwx3MyQJjW6ZGAYtIcwJ8Va1jBRt3yBPv8Hug1z9Fmfyl0m5QLNKHmLMjGkFKG_u4YStRirtupoglqMVYTlIHnu2Z9S7qZ-OflbK-QP3TuIKhkH2R3rIphJ2eD-s-Inu8-1mw</recordid><startdate>20240917</startdate><enddate>20240917</enddate><creator>Duggar, Christopher</creator><creator>Santoli, Jeanne M.</creator><creator>Noblit, Cameron</creator><creator>Moore, Lori B.</creator><creator>El Kalach, Roua</creator><creator>Bridges, Carolyn B.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240917</creationdate><title>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</title><author>Duggar, Christopher ; Santoli, Jeanne M. ; Noblit, Cameron ; Moore, Lori B. ; El Kalach, Roua ; Bridges, Carolyn B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-926430a72d3efced8bb26a560afd54ad734881db201c4cae95577d40008096e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>At risk populations</topic><topic>Centers for Disease Control and Prevention, U.S</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 pandemic</topic><topic>COVID-19 vaccine</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - administration &amp; dosage</topic><topic>Disease control</topic><topic>Drug stores</topic><topic>Emergency preparedness</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Immunization</topic><topic>Immunization Programs - organization &amp; administration</topic><topic>Information systems</topic><topic>Infrastructure</topic><topic>Inventory</topic><topic>Islands</topic><topic>Lessons learned</topic><topic>Medicaid</topic><topic>Older people</topic><topic>Pandemics</topic><topic>Pandemics - prevention &amp; control</topic><topic>Pediatrics</topic><topic>Pharmacy</topic><topic>Public health</topic><topic>SARS-CoV-2 - immunology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Swine flu</topic><topic>United States - epidemiology</topic><topic>Vaccination</topic><topic>Vaccine distribution</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duggar, Christopher</creatorcontrib><creatorcontrib>Santoli, Jeanne M.</creatorcontrib><creatorcontrib>Noblit, Cameron</creatorcontrib><creatorcontrib>Moore, Lori B.</creatorcontrib><creatorcontrib>El Kalach, Roua</creatorcontrib><creatorcontrib>Bridges, Carolyn B.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duggar, Christopher</au><au>Santoli, Jeanne M.</au><au>Noblit, Cameron</au><au>Moore, Lori B.</au><au>El Kalach, Roua</au><au>Bridges, Carolyn B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2024-09-17</date><risdate>2024</risdate><volume>42</volume><issue>Suppl 3</issue><spage>125703</spage><epage>125703</epage><pages>125703-125703</pages><artnum>125703</artnum><issn>0264-410X</issn><issn>1873-2518</issn><eissn>1873-2518</eissn><abstract>During December 2020 through May 2023, the Centers for Disease Control and Prevention’s (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures. This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>38360476</pmid><doi>10.1016/j.vaccine.2024.02.020</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2024-09, Vol.42 (Suppl 3), p.125703-125703, Article 125703
issn 0264-410X
1873-2518
1873-2518
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11366301
source MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects At risk populations
Centers for Disease Control and Prevention, U.S
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 pandemic
COVID-19 vaccine
COVID-19 vaccines
COVID-19 Vaccines - administration & dosage
Disease control
Drug stores
Emergency preparedness
Humans
Illnesses
Immunization
Immunization Programs - organization & administration
Information systems
Infrastructure
Inventory
Islands
Lessons learned
Medicaid
Older people
Pandemics
Pandemics - prevention & control
Pediatrics
Pharmacy
Public health
SARS-CoV-2 - immunology
Severe acute respiratory syndrome coronavirus 2
Swine flu
United States - epidemiology
Vaccination
Vaccine distribution
Vaccines
title U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T15%3A18%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=U.S.%20COVID-19%20vaccine%20distribution%20strategies,%20systems,%20performance,%20and%20lessons%20learned,%20December%202020%20%E2%80%93%20May%202023&rft.jtitle=Vaccine&rft.au=Duggar,%20Christopher&rft.date=2024-09-17&rft.volume=42&rft.issue=Suppl%203&rft.spage=125703&rft.epage=125703&rft.pages=125703-125703&rft.artnum=125703&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2024.02.020&rft_dat=%3Cproquest_pubme%3E2928247931%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3132559282&rft_id=info:pmid/38360476&rft_els_id=S0264410X24001671&rfr_iscdi=true